1,394
Views
29
CrossRef citations to date
0
Altmetric
Clinical Focus: Neurological and Psychiatric Disorders - Review

A systematic review on the impact of psychotropic drugs on electroencephalogram waveforms in psychiatry

, &
Pages 656-664 | Received 18 May 2016, Accepted 26 Jul 2016, Published online: 08 Aug 2016

References

  • Boutros N. Effects of psychotropic drugs on the EEG. Standard EEG: a research roadmap for neuropsychiatry. Cham: Springer; 2013. p. 27–33.
  • Galderisi S, Sannita WG. Pharmaco-EEG: a history of progress and a missed opportunity. Clin EEG Neurosci. 2006;37:61–65.
  • Nuwer M. Assessment of digital EEG, quantitative EEG and EEG brain mapping. Rep Am Acad Neurol Am Clin Neurophysiol Soc Neurol. 1997;49:277–292.
  • Mucci A, Volpe U, Merlotti E, et al. Pharmaco-EEG in psychiatry. Clin EEG Neurosci. 2006;37:81–98.
  • Knott V, Mahoney C, Kennedy S, et al. Pre-treatment EEG and its relationship to depression severity and paroxetine treatment outcome. Pharmacopsychiatry. 2000;33:201–205.
  • Siepmann M, Grossmann J, Mück-Weymann M, et al. Effects of sertraline on autonomic and cognitive functions in healthy volunteers. Psychopharmacology. 2003;168:293–298.
  • Saletu B, Anderer P, Saletu-Zyhlarz GM. EEG topography and tomography (LORETA) in the classification and evaluation of the pharmacodynamics of psychotropic drugs. Clin EEG Neurosci. 2006;37:66–80.
  • Clemens B, Menes A, Piros P, et al. Quantitative EEG effects of carbamazepine, oxcarbamazepine, valproate, lamotrigine and possible clinical relevance of the findings. Epilepsy Res. 2006;70(2–3):190–199.
  • Salinsky MC, Oken BS, Storzbach D, et al. Assessment of CNS effects of antiepileptic drugs by using quantitative EEG measures. Epilepsia. 2003;44:1042–1050.
  • Galderisi S, Mucci A, Volpe U, et al. Evidence-based medicine and electrophysiology in schizophrenia. Clin EEG Neurosci. 2009;40:62–77.
  • Smith SJM. EEG in neurological conditions other than epilepsy: when does it help, what does it add? J Neurol Neurosurg Psychiatry. 2005;76(2):ii8–ii12.
  • Hirsch LJ. ACNS standardized EEG research terminology and categorization for the investigation of rhythmic and periodic patterns encountered in critically ill patients: July 2009 version. J Clin Neurophysiol. 2005;22(2):128–135.
  • Macaluso M, Zackula R, D’Empaire I, et al. Twenty percent of a representative sample of patients taking bupropion have abnormal, asymptomatic electroencephalographic findings. J Clin Psychopharmacol. 2010;30(3):312–317.
  • Hunter AM, Leuchter AF, Cook IA, et al. Brain functional changes and duloxetine treatment response in fibromyalgia: a pilot study. Pain Med. 2009;10(4):730–738.
  • Bares M, Brunovsky M, Kopecek M, et al. Early reduction in prefrontal theta QEEG cordance value predicts response to venlafaxine treatment in patients with resistant depressive disorder. Eur Psychiatry. 2008;23(5):350–355.
  • Iosifescu DV, Greenwald S, Devlin P, et al. Frontal EEG predictors of treatment outcome in major depressive disorder. Eur Neuropsychopharmacol. 2009;19(11):772–777.
  • Hunter AM, Cook IA, Leuchter AF. Does prior antidepressant treatment of major depression impact brain function during current treatment? Eur Neuropsychopharmacol. 2012;22(10):711–720.
  • Okumura A, Kubota T, Tsuji T, et al. Amplitude spectral analysis of theta/alpha/beta waves in preterm infants. Pediatr Neurol. 2006;34(1):30–34.
  • Jaworska N, Blondeau C, Tessier P, et al. Examining relations between alpha power as well as anterior cingulate cortex-localized theta activity and response to single or dual antidepressant pharmacotherapies. J Psychopharmacol. 2014;28(6):587–595.
  • Tenke EC, Kayser J, Manna CG, et al. Current source density measures of EEG alpha predict antidepressant treatment response. Biol Psychiatry. 2011;70(4):388–394.
  • Bruder GE, Sedoruk JP, Steward JW, et al. EEG alpha measures predict therapeutic response to an SSRI antidepressant: pre and post treatment findings. Biol Psychiatry. 2008;63(12):1171–1177.
  • Knott V, Mahoney C, Kennedy S, et al. EEG correlates of acute and chronic paroxetine treatment in depression. J Affect Disord. 2002;69(1–3):241–249.
  • MacCrimmon D, Brunet D, Criollo M, et al. Clozapine augments delta, theta and right frontal EEG power in schizophrenic patients. International Scholarly Research Notices: Psychiatry. ISRN Psychiatry, Hindawi Publishing; 2012; Article ID 596486.
  • Hyun J, Baik MJ, Kang UG. Effects of psychotropic drugs on quantitative EEG among patients with schizophrenia-spectrum disorders. Clin Psychopharmacol Neurosci: Off Sci Korean Coll Neuropsychopharmacol. 2011;9(2):78–85.
  • Khodayari-Rostamabad A, Hasey GM, MacCrimmon DJ, et al. A pilot study to determine whether machine learning methodologies using pre-treatment electroencephalography can predict the symptomatic response to clozapine therapy. Clin Neurophysiol. 2010;121(12):1998–2006.
  • Goyal N, Praharaj SK, Desarkar P, et al. Electroencephalographic abnormalities in clozapine-treated patients: a cross-sectional study. Psychiatry Investig. 2011;8(4):372–376.
  • Knott VJ, LaBelle A, Jones B, et al. EEG coherence following acute and chronic clozapine in treatment-resistant schizophrenics. Exp Clin Psychopharmacol. 2002;10(4):434–444.
  • Knott V, Labelle A, Jones B, et al. Quantitative EEG in schizophrenia and in response to acute and chronic clozapine treatment. Schizophr Res. 2001;50(1–2):41–53.
  • Boutros N. Standard EEG: a research roadmap for neuropsychiatry. Cham: Springer International Publishing; 2013. p. 35–37.
  • Centorrino F, Price BH, Tuttle M, et al. EEG abnormalities during treatment with typical and atypical antipsychotics. Am J Psychiatry. 2002;159(1):109–115.
  • Liem-Moolenaar M, Gray FA, de Visser SJ, et al. Psychomotor and cognitive effects of a single oral dose of talnetant (SB223412) in healthy volunteers compared with placebo or haloperidol. J Psychopharmacol. 2010;24(1):73–82.
  • Yoshimura M, Koenig T, Irisawa S, et al. A pharmaco-EEG study on antipsychotic drugs in healthy volunteers. Psychopharmacology. 2007;191(4):995–1004.
  • Begic D, Hotujac L, Jokic-Begic N. Quantitative EEG in schizophrenic patients before and during pharmacotherapy. Neuropsychobiology. 2000;41(3):166–170.
  • Diekmann V, Grozinger B, Westphal KP, et al. Changes in EEG order in neuroleptically treated normal volunteers during a voluntary movement task. J Neural Transm. 1996;103(8–9):1127–1139.
  • Kemali D, Galderisi S, Maj M, et al. Computerize EEG topography findings in schiozphrenic patients before and after haloperidol treatment. Int J Psychophysiol. 1992;13(3):283–290.
  • McClelland GR, Cooper SM, Pilgrim AJ. A comparison of the central nervous system effects of haloperidol, chlorpromazine and sulpiride in normal volunteers. Br J Clin Pharmacol. 1990;30(6):795–803.
  • Thau K, Rappelsberger P, Lovrek A, et al. Effect of lithium on the EEG of healthy males and females. A probability mapping study. Neuropsychobiology. 1989;20(3):158–163.
  • Henninger GR. Lithium carbonate and brain function. Cerebral-evoked potentials, EEG and symptom changes during lithium carbonate treatment. Arch Gen Psychiatry. 1978;35(2):228–233.
  • Mecarelli O, Vicennzini E, Pulitano P, et al. Clinical, cognitive and neurophysiologic correlates of short-term treatment with carbamazepine, oxcarbamazepine and levetiracetam in healthy volunteers. Ann Pharmacother. 2004;38(11):1816–1822.
  • Marciani MG, Gigli GL, Maschio MC, et al. EEG changes induced by carbamazepine therapy at rest and during mental processes. Ital J Neurol Sci. 1992;13(9):729–733.
  • Besser R, Hormung K, Theisohn M, et al. EEG changes in patients during the introduction of carbamazepine. Electroencephalogr Clin Neurophysiol. 1992;83(1):19–23.
  • Salinsky MC, Binder LM, Oken BS, et al. Effects of gabapentin and carbamazepine on the EEG and cognition in healthy volunteers. Epilepsia. 2002;43(5):482–490.
  • Wu X, Xiao CH. Quantitative pharmaco-EEG of carbamazepine in volunteers and epileptics. Clin Electroencephalogram. 1996;27(1):40–45.
  • Frost JD, Hrachovy RA, Glaze DG, et al. Alpha rhythm slowing during initiation of carbamazepine therapy: implications for future cognitive performance. J Clin Neurophysiol. 1995;12(1):57–63.
  • Clemens B, Puskas S, Besenyei M, et al. Valproate treatment normalizes EEG functional connectivty in successfully treated idiopathic generalized epilepsy patietnts. Epilepsy Res. 2014;108(10):1896–1903.
  • Arzy S, Allali G, Brunet D, et al. Antiepileptic drugs modify power of high EEG frequencies and their neural generators. Eur J Neurol. 2010;17(10):1308–1312.
  • Guo J, Wang D, Ren M, et al. QPEEG analysis of the effects of sodium valproate on adult Chinese patients with generalized tonic-clonic seizures. Metab Brain Dis. 2014;29(3):801–807.
  • Villarreal HJ, Wilder BJ, Willmore LJ, et al. Effect of valproic acid on spike and wave discharge in patients with absence seizures. Neurology. 1978;28(9):886–891.
  • Muhle H, Ettle E, Boor R, et al. Valproate reduces spontaneous generalized spikes and waves but not photparoxysmal reactions in patients with idiopathic generalized spikes. Epiepsia. 2011;52(7):1297–1302.
  • Clemens B, Piros P, Bessenyei M, et al. Imaging the cortical effect of lamotrigine in patients with idiopathic-generalized epilepsy: a low-resolution electromagnetic tomography (LORETA) study. Epilepsy Res. 2008;81(2–3):204–210.
  • Clemens B, Piros P, Bessenyei M, et al. Lamotrigine decreases EEG synchronization in a use-dependent manner in patients with idiopathic generalized epilepsy. Clin Neurophysiol: Off J Int Fed Clin Neurophysiol. 2007;118(4):910–917.
  • Foletti G, Volanschi D. Influence of lamotrigine addition on computerized background EEG parameters in severe epileptogenic encephalopathies. Eur Neurol. 1994;34(1):87–89.
  • Covanis A, Stodieck SRG, Wilkin AJ. International league against epilepsy treatment of photosensitivity. Epilepsia. 2004;45(Suppl.1):40–45.
  • Saletu B, Grunberger J, Linzmayer L. Evaluation of encephalotropic and psychotropic properties of gabapentin in man by pharmaco-EEG and psychometry. Int J Clin Pharmacol. 1986;24(7):362–373.
  • Mercarelli O, Piacenti A, Pulitano P, et al. Clinical and electroencephaographic effects of topiramate in patients with epilepsy and healthy volunteers. Clin Neuropharmacol. 2001;24(5):284–289.
  • Wang WW, Li JC, Wu X. Quantitative EEG effects of topiramate. Clin Electroencephalogram. 2003;34(2):87–92.
  • Paes F, Machado S, Arias-Carrion O, et al. Effects of Methylphenidate on performance of a practical pistol shooting task: a quantitative electronecphalography (qEEG) study. Int Archves Med. 2011;4(1):6.
  • Korostenskaja M, Kicic D, Kahkonen S. The effect of methylphenidate on auditory information processing in healthy volunteers: a combined EEG/MEG study. Psychopharmacology. 2008;197(3):475–486.
  • Shenton ME, Faux SF, McCarley RW, et al. Clinical correlations of auditory P200 topography and left temporo-central deficits in schizophrenia: a preliminary study. J Psychiatr Res. 1989;23(1):13–34.
  • Panayiotopoulos CP. The epilepsies: seizures, syndromes and management. Oxfordshire: Bladon Medical Publishing; 2005.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.